Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Lymphoma and ABCG2[original query] |
---|
ABCG2 Q141K polymorphism is associated with chemotherapy-induced diarrhea in patients with diffuse large B-cell lymphoma who received frontline rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone chemotherapy. Cancer science 2008 Dec 99 (12): 2496-501. Kim In-Suk, Kim Hoon-Gu, Kim Dong Chul, Eom Hyeon-Seok, Kong Sun-Young, Shin Ho-Jin, Hwang Sang-Hyun, Lee Eun-Yup, Lee Gyeong-W |
A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk. International journal of cancer. Journal international du cancer 2012 Aug 131 (4): 803-12. Campa Daniele, Butterbach Katja, Slager Susan L, Skibola Christine F, de Sanjosé Silvia, Benavente Yolanda, Becker Nikolaus, Foretova Lenka, Maynadie Marc, Cocco Pierluigi, Staines Anthony, Kaaks Rudolf, Boffetta Paolo, Brennan Paul, Conde Lucia, Bracci Paige M, Caporaso Neil E, Strom Sara S, Camp Nicola J, Cerhan James R, Consortium Gec, Canzian Federico, Nieters Alexand |
Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies. Pharmacogenomics 2014 Aug 15 (11): 1479-94. Suthandiram Sujatha, Gan Gin-Gin, Zain Shamsul Mohd, Bee Ping-Chong, Lian Lay-Hoong, Chang Kian-Meng, Ong Tee-Chuan, Mohamed Zahur |
ABCG2 and NCF4 polymorphisms are associated with clinical outcomes in diffuse large B-cell lymphoma patients treated with R-CHOP. Oncotarget 2017 Aug 8 (35): 58292-58303. Liu Duo, Wu Nan, Sun Haiming, Dong Mei, Guo Tianzhu, Chi Peng, Li Guofu, Sun Donglin, Jin Y |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: